Bayer-Monsanto deal wins Russian approval, moves closer to closing
Russian antitrust regulators have approved Bayer’s planned $66 billion acquisition of Monsanto, Bayer said, checking one of the few remaining jurisdictions off the list of those that have yet to approve the deal.
Bayer agreed “to enable the transfer of defined technologies to Russian recipients in the area of seeds breeding and digital farming for a period of five years,” according to a statement.
Bayer, the German chemical and pharmaceutical company, won conditional European clearance of the deal for Creve Coeur-based Monsanto last month. U.S. regulators approved the deal earlier this month, the Wall Street Journal has reported, citing people familiar with the matter.